(Q33372491)

English

Specificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: a relation to their history of thromboembolic disease

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Specificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: a relation to their history of thromboembolic disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

anticoagulation

1 reference

based on heuristic

inferred from title

thromboembolism

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Katharina Schallmoser

object named as

K Schallmoser

1

0 references

Daniela Dunkler

object named as

D Dunkler

5

0 references

author name string

C Rosin

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

R Vormittag

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M Brunner

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

I Pabinger

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S Panzer

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

507-514

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Specificities of platelet autoantibodies in patients with lupus anticoagulants in primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Serum from patients with chronic idiopathic thrombocytopenic purpura frequently affect the platelet function

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Platelet function and immune response

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface.

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Anti‐platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant.

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Autoimmune thrombocytopenic purpura and the compensated thrombocytolytic state

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Platelet-associated CD154 in immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Pathophysiology of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1191%2F0961203306LU2341OA

21 January 2018

Identifiers

10.1191/0961203306LU2341OA

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33372491&oldid=2043612935"